There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Articles by Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Latest Updated Articles
Monoclonal Antibodies Show Promise Treating COVID-19Published: January 13th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
5
